Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

Recursion Pharmaceuticals is trying to prove that AI’s next big winner can also come from biotech, and not just from the tech ...

Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive early clinical data from its AI driven drug discovery programs. The company highlighted progress in oncology and rare disease candidates in ...

The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...

Detailed price information for Roche Holding Ltd ADR (RHHBY) from The Globe and Mail including charting and trades.

USA News Group, There is a growing consensus in artificial intelligence that the models themselves are becoming interchangeable, and that ...

The maker of Claude wants the world to keep one option open. The timing is the tell.

As AI moves from experimentation to business-critical operations, leadership teams will need to look beyond pilot outcomes and technical performance.